Rhumbline Advisers Utah Medical Products Inc Transaction History

Rhumbline Advisers

$109 Billion
Q3 2024

A detailed history of Rhumbline Advisers transactions in Utah Medical Products Inc stock. As of the latest transaction made, Rhumbline Advisers holds 6,645 shares of UTMD stock, worth $404,746. This represents 0.0% of its overall portfolio holdings.

Number of Shares

6,645

Previous 5,508 20.64%

Holding current value

$404,746

Previous $367,000 20.98%

% of portfolio

0.0%

Previous 0.0%

28 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$65.79 - $75.08 $74,803 - $85,365	1,137 Added 20.64%	6,645 $444,000
Q2 2024 Aug 01, 2024	BUY	$65.92 - $70.99 $53,527 - $57,643	812 Added 17.29%	5,508 $367,000
Q1 2024 May 09, 2024	BUY	$68.14 - $84.23 $10,766 - $13,308	158 Added 3.48%	4,696 $333,000
Q4 2023 Feb 08, 2024	SELL	$77.07 - $87.05 $6,550 - $7,399	-85 Reduced 1.84%	4,538 $382,000
Q3 2023 Nov 09, 2023	BUY	$83.86 - $99.16 $10,398 - $12,295	124 Added 2.76%	4,623 $397,000
Q2 2023 Aug 08, 2023	SELL	$87.76 - $99.95 $7,371 - $8,395	-84 Reduced 1.83%	4,499 $419,000
Q1 2023 May 11, 2023	BUY	$87.14 - $100.3 $7,145 - $8,224	82 Added 1.82%	4,583 $434,000
Q4 2022 Feb 14, 2023	BUY	$82.45 - $101.88 $9,234 - $11,410	112 Added 2.55%	4,501 $452,000
Q3 2022 Nov 10, 2022	BUY	$80.73 - $95.26 $22,200 - $26,196	275 Added 6.68%	4,389 $374,000
Q2 2022 Aug 11, 2022	SELL	$81.49 - $90.28 $39,685 - $43,966	-487 Reduced 10.58%	4,114 $353,000
Q1 2022 May 12, 2022	SELL	$86.04 - $99.89 $33,813 - $39,256	-393 Reduced 7.87%	4,601 $413,000
Q4 2021 Feb 10, 2022	SELL	$88.84 - $124.71 $4,619 - $6,484	-52 Reduced 1.03%	4,994 $499,000
Q3 2021 Nov 12, 2021	BUY	$84.89 - $97.16 $14,855 - $17,003	175 Added 3.59%	5,046 $468,000
Q2 2021 Aug 05, 2021	BUY	$82.4 - $89.39 $33,866 - $36,739	411 Added 9.22%	4,871 $414,000
Q1 2021 May 06, 2021	SELL	$83.74 - $92.99 $12,561 - $13,948	-150 Reduced 3.25%	4,460 $386,000
Q4 2020 Feb 10, 2021	BUY	$79.35 - $94.4 $27,851 - $33,134	351 Added 8.24%	4,610 $389,000
Q3 2020 Nov 12, 2020	SELL	$78.22 - $92.62 $48,809 - $57,794	-624 Reduced 12.78%	4,259 $340,000
Q2 2020 Aug 13, 2020	BUY	$78.0 - $106.28 $8,970 - $12,222	115 Added 2.41%	4,883 $433,000
Q4 2019 Feb 05, 2020	BUY	$91.85 - $109.3 $3,214 - $3,825	35 Added 0.74%	4,768 $514,000
Q3 2019 Oct 23, 2019	BUY	$83.55 - $100.0 $5,681 - $6,800	68 Added 1.46%	4,733 $454,000
Q2 2019 Aug 14, 2019	SELL	$77.76 - $95.7 $544 - $669	-7 Reduced 0.15%	4,665 $446,000
Q1 2019 May 01, 2019	BUY	$80.49 - $99.2 $2,495 - $3,075	31 Added 0.67%	4,672 $412,000
Q4 2018 Jan 31, 2019	BUY	$74.64 - $97.62 $117,632 - $153,849	1,576 Added 51.42%	4,641 $386,000
Q3 2018 Nov 07, 2018	SELL	$86.0 - $114.75 $17,200 - $22,950	-200 Reduced 6.13%	3,065 $289,000
Q2 2018 Aug 06, 2018	BUY	$95.3 - $116.0 $12,960 - $15,776	136 Added 4.35%	3,265 $360,000
Q1 2018 May 02, 2018	SELL	$79.3 - $99.1 $6,344 - $7,928	-80 Reduced 2.49%	3,129 $309,000
Q4 2017 Feb 09, 2018	SELL	$74.4 - $84.05 $44,788 - $50,598	-602 Reduced 15.8%	3,209 $261,000
Q3 2017 Nov 06, 2017	BUY	$68.55 - $74.65 $261,244 - $284,491	3,811	3,811 $280,000

Others Institutions Holding UTMD

# of Institutions

108

Shares Held

2.11M

Call Options Held

Put Options Held

View Full List

About UTAH MEDICAL PRODUCTS INC

Ticker UTMD
Exchange NASDAQ
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 3,625,200
Market Cap $221M
Description
Utah Medical Products, Inc. develops, manufactures, and distributes medical devices for the healthcare industry. The company offers fetal monitoring accessories, vacuum-assisted delivery systems, and other labor and delivery tools; DISPOSA-HOOD infant respiratory hoods; and DELTRAN PLUS blood pressure monitoring systems. It also provides GESCO u...

More about UTMD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.

Account

Rhumbline Advisers Utah Medical Products Inc Transaction History